These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

201 related articles for article (PubMed ID: 4164172)

  • 41. [Experience with preventive measles, mumps and rubella vaccination in unified Germany].
    Gerike E; Tischer A
    Gesundheitswesen; 1993 Jan; 55(1):38-9. PubMed ID: 8435543
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Results of the inoculation test of measles vaccine. 3. The result of Schwarz vaccine (highly attenuated live virus vaccine)].
    Santo K
    Nihon Shonika Gakkai Zasshi; 1967 Mar; 71(3):356-60. PubMed ID: 6070598
    [No Abstract]   [Full Text] [Related]  

  • 43. Studies on the combined use of killed and live measles vaccines. II. Advantages of the inhalation method.
    Okuno Y; Ueda S; Hosai H; Kitawaki T; Nakamura K; Chiang TP; Okabe S; Onaka M; Toyoshima K
    Biken J; 1965 Jun; 8(2):81-5. PubMed ID: 5837767
    [No Abstract]   [Full Text] [Related]  

  • 44. [Dynamics of the serologic response of children vaccinated with live AMN USSR measles vaccine prepared from the ESzCz strain].
    Sinjak KM; Czumakow MP; Rodin WI; Czudnaja LM; Sziechtier AB; Winograd IA; Urin AI; Glinskaja LA; Szwiec LT; Knjaziewa II; Niemiec ZA
    Przegl Epidemiol; 1970; 24(1):15-20. PubMed ID: 5431385
    [No Abstract]   [Full Text] [Related]  

  • 45. [Clinical and immunological prospective study of the measles live virus vaccine].
    Sujoy E; Blaksley JC; Shepherd G; Simsolo V; Palais L; Pizzia A; Becker D; Behar M; Morgenstern O
    Arch Argent Pediatr; 1966; 63(7):260-5. PubMed ID: 5990418
    [No Abstract]   [Full Text] [Related]  

  • 46. [Specific prevention of measles in Rumania. V. Studies on an attenuated live measles virus vaccine prepared at the Stefan S. Nicolau Institute of Virology and administered in various ways].
    Cajal N; Cepleanu M; Cernesc C; Sorodoc Y; Tigăeru N; Biberi-Moroianu S; Cuciu D; Brebenel G; Vucu E; Petrescu A
    Stud Cercet Virusol; 1973; 24(5):349-56. PubMed ID: 4747453
    [No Abstract]   [Full Text] [Related]  

  • 47. Application of live attenuated measles and mumps vaccines in children with acute leukemia.
    Torigoe S; Hirai S; Oitani K; Ito M; Ihara T; Iwasa T; Kamiya H; Sakurai M; Ueda S; Yamanishi K
    Biken J; 1981 Dec; 24(4):147-51. PubMed ID: 7346040
    [TBL] [Abstract][Full Text] [Related]  

  • 48. A serological study of children vaccinated against measles.
    Strauss J; Zdrazílek J; Svandová E; Sejda J; Helcl J
    J Hyg Epidemiol Microbiol Immunol; 1969; 13(4):468-81. PubMed ID: 5391988
    [No Abstract]   [Full Text] [Related]  

  • 49. [Studies of the live AMN USSR measles vaccine from the ESC strain and its use and problems of mass vaccinations against measles].
    Czumakow MP; Woroszylowa MK; Graczew WP; Sinjak KM; Bojko WM; Sejbil WB; Rodin WI; Piwień GG
    Przegl Epidemiol; 1970; 24(2):205-11. PubMed ID: 5431794
    [No Abstract]   [Full Text] [Related]  

  • 50. Persistent immunity following Enders live, attenuated measles-virus vaccine given with human immune globulin.
    STOKES J; HILLEMAN MR; WEIBEL RE; BUYNAK EB; HALENDA R
    N Engl J Med; 1962 Aug; 267():222-4. PubMed ID: 13917379
    [No Abstract]   [Full Text] [Related]  

  • 51. Current status of measles immunization.
    JAMA; 1965 Dec; 194(11):1237-8. PubMed ID: 4158503
    [No Abstract]   [Full Text] [Related]  

  • 52. [Clinical immunoserological study of combined innoculation of inactivated and live measles vaccines].
    Yamazaki Y
    Nihon Shonika Gakkai Zasshi; 1969 May; 73(5):644-55. PubMed ID: 5817193
    [No Abstract]   [Full Text] [Related]  

  • 53. [Combined inoculation of inactivated and attenuated measles vaccines].
    Shih A
    Nihon Shonika Gakkai Zasshi; 1969 Jul; 73(7):1003-10. PubMed ID: 5390046
    [No Abstract]   [Full Text] [Related]  

  • 54. [Measles vaccination. Israeli studies with live attenuated measles virus vaccine and gamma globulin].
    LEVIN S; MOSES S; SHIMANSKY L; KRUGMAN S
    Harefuah; 1962 Sep; 63():161-6. PubMed ID: 14464579
    [No Abstract]   [Full Text] [Related]  

  • 55. Seroconversion following measles immunisation.
    Mittal SK; Gulati A; Kumari P; Bala V; Gupta S
    Indian Pediatr; 1979 Apr; 16(4):309-11. PubMed ID: 511301
    [No Abstract]   [Full Text] [Related]  

  • 56. MEASLES VACCINE FIELD TRIALS IN ALASKA. I. KILLED VACCINE FOLLOWED BY LIVE ATTENUATED VACCINE AND GAMMA-GLOBULIN WITH LIVE ATTENUATED VACCINE.
    BRODY JA; MCALISTER R; EMANUEL I; ALEXANDER ER
    JAMA; 1964 Aug; 189():339-42. PubMed ID: 14160504
    [No Abstract]   [Full Text] [Related]  

  • 57. Measles immune globulin. Proposed standard dose given with liver attenuated measles virus vaccine.
    Warren RJ; Nader PR; Levine RH
    JAMA; 1968 Jan; 203(3):186-8. PubMed ID: 4169348
    [No Abstract]   [Full Text] [Related]  

  • 58. DURABLE IMMUNITY TWO YEARS AFTER ADMINISTRATION OF ENDERS'S LIVE MEASLES-VIRUS VACCINE WITH IMMUNE GLOBULIN.
    WEIBEL RE; STOKES J; HALENDA R; BUYNAK EB; HILLEMAN MR
    N Engl J Med; 1964 Jan; 270():172-5. PubMed ID: 14068089
    [No Abstract]   [Full Text] [Related]  

  • 59. Ender's live measles-virus vaccine with human immune globulin. II. Evaluation of efficacy.
    HILLEMAN MR; STOKES J; BUYNAK EB; WEIBEL R; HALENDA R; GOLDNER H
    Am J Dis Child; 1962 Mar; 103():372-9. PubMed ID: 13907410
    [No Abstract]   [Full Text] [Related]  

  • 60. Immunoglobulins on measles vaccine inoculation or measles virus infection--particularly, on 2-mercaptoethanol sensitive and resistant antibodies.
    Arai M; Nakamura M
    Acta Paediatr Jpn; 1970 Dec; 12(2):9-15. PubMed ID: 4100594
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.